Sequencing of erdafitinib (erda) and enfortumab vedotin (EV) in patients (pts) with fibroblast growth factor receptor (FGFR2/3) altered (alt) advanced urothelial cancer (aUC): Analysis of UNITE database.

Authors :: Jiang, Cindy Y.
Hwang, Hyunsoo
Jindal, Tanya
Qiao, Wei
Epstein, Ilana
Nguyen, Charles B
Gupta, Shilpa
Shah, Sumit
Bilen, Mehmet Asim
Milowsky, Matthew I.
Hoimes, Christopher J.
Kilari, Deepak
Zakharia, Yousef
Emamekhoo, Hamid
Grivas, Petros
Bellmunt, Joaquim
Alva, Ajjai Shivaram
Koshkin, Vadim S
Campbell, Matthew T
Alhalabi, Omar
Source :: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p616-616, 193p
Publication Year :: 2024

Full Text Access

Tools